<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0213264</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1117</journal-id>
<journal-id journal-id-type="nlm-ta">Biol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Biol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Biological psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-3223</issn>
<issn pub-type="epub">1873-2402</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29373119</article-id>
<article-id pub-id-type="pmc">5984669</article-id>
<article-id pub-id-type="doi">10.1016/j.biopsych.2017.11.025</article-id>
<article-id pub-id-type="manuscript">NIHMS925488</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Nuclear-Excluded Autism-Associated PTEN Mutations Dysregulate Neuronal Growth</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Fricano-Kugler</surname>
<given-names>Catherine J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Getz</surname>
<given-names>Stephanie A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Williams</surname>
<given-names>Michael R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zurawel</surname>
<given-names>Ashley A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>DeSpenza</surname>
<given-names>Tyrone</given-names>
<suffix>Jr.</suffix>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Frazel</surname>
<given-names>Paul W.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Meijie</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>O’Malley</surname>
<given-names>Alistair J.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moen</surname>
<given-names>Erika L.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luikart</surname>
<given-names>Bryan W.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Physiology and Neurobiology, Geisel School of Medicine at Dartmouth College, Lebanon, New Hampshire 03756</aff>
<aff id="A2">
<label>2</label>The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA</aff>
<aff id="A3">
<label>3</label>Department of Biomedical Data Science, The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding Author- <email>Bryan.w.luikart@dartmouth.edu</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p>
<bold>Financial Disclosures</bold>
</p>
<p>The authors report no biomedical financial interests or potential conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>5</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>02</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>8</month>
<year>2019</year>
</pub-date>
<volume>84</volume>
<issue>4</issue>
<fpage>265</fpage>
<lpage>277</lpage>
<!--elocation-id from pubmed: 10.1016/j.biopsych.2017.11.025-->
<abstract>
<sec id="S1">
<title>Background</title>
<p id="P1">Phosphatase and tensin homolog (PTEN) negatively regulates downstream AKT signaling resulting in decreased cellular growth and proliferation. PTEN is mutated in a subset of children with autism spectrum disorder (ASD); however, the mechanism by which specific point mutations alter PTEN function is largely unknown. Here, we assess how ASD-associated single-nucleotide variations in PTEN (ASD-PTEN) affect function.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">We use viral-mediated molecular substitution of human PTEN into Pten knockout mouse neurons and assess neuronal morphology to determine the functional impact of ASD-PTEN. We employ molecular cloning to examine how PTEN’s stability, subcellular localization, and catalytic activity impact neuronal growth.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">We identify a set of ASD-PTEN mutations displaying altered lipid phosphatase function and subcellular localization. We demonstrate that wild-type PTEN can rescue the neuronal hypertrophy, while PTEN H93R, F241S, D252G, W274L, N276S and D326N fail to rescue this hypertrophy. A subset of these mutations lacks nuclear localization prompting us to examine the role of nuclear PTEN in regulating neuronal growth. We find that nuclear PTEN alone is sufficient to regulate soma size. Further, forced localization of the D252G and W274L mutations into the nucleus partially restore regulation of soma size.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">ASD-PTEN mutations display decreased stability, catalytic activity, and/or altered subcellular localization. Mutations lacking nuclear localization uncover a novel mechanism whereby lipid phosphatase activity in the nucleus can regulate mTOR signaling and neuronal growth.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Autism</kwd>
<kwd>dentate gyrus</kwd>
<kwd>PTEN</kwd>
<kwd>neuron</kwd>
<kwd>hypertrophy</kwd>
<kwd>ASD</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>